Chen Rui, Zheng Xin, Hu Pei
Clinical Pharmacology Research Center, Peking Union Medical College HospitalBeijing, China.
Front Pharmacol. 2017 May 2;8:239. doi: 10.3389/fphar.2017.00239. eCollection 2017.
Asian populations have around 40-60% frequency of reduced function allele compared to 1-2% in Caucasian populations. The wide range of enzyme activities in subjects with the variant is a big concern for clinical practice. The quantitative analysis measuring the impact of enzyme activity as a result of one allele or two alleles has not been reported in large Asian populations. A total of 421 healthy Chinese subjects were genotyped for by polymerase chain reaction and direct DNA sequencing. A total of 235 subjects with ( = 22), ( = 93), ( = 85), and ( = 35) were phenotyped for using dextromethorphan as the probe drug. Metabolic ratios (MR) were calculated as the ratio of parent drug to metabolite in 0-3 h urine, 3 h plasma, and 3 h saliva for each sample type. The urinary, plasma, or salivary MRs increased successively in subjects with , , , and (all < 0.001). In the normal metabolizer group, homozygous decreased the enzyme activity further than heterozygous . Urinary, plasma, and salivary MRs were highly correlated. The normal metabolizer group calls for a more detailed classification. The activity score system could more accurately predict enzyme activity than by grouping a number of genotypes into a single phenotype group. Single-point plasma samples and saliva samples could be used as alternative phenotyping methods for clinical convenience.
与白种人人群中1%-2%的频率相比,亚洲人群中功能降低等位基因的频率约为40%-60%。携带该变体的受试者中酶活性范围广泛,这是临床实践中一个重大问题。在大型亚洲人群中,尚未报道过测量一个等位基因或两个等位基因对酶活性影响的定量分析。通过聚合酶链反应和直接DNA测序对总共421名健康中国受试者进行了基因分型。总共235名携带(=22)、(=93)、(=85)和(=35)的受试者使用右美沙芬作为探针药物进行了表型分析。代谢率(MR)计算为每个样本类型在0-3小时尿液、3小时血浆和3小时唾液中母体药物与代谢物的比率。携带、、、的受试者的尿液、血浆或唾液MR依次升高(均<0.001)。在正常代谢者组中,纯合子比杂合子进一步降低了酶活性。尿液、血浆和唾液MR高度相关。正常代谢者组需要更详细的分类。与将多种基因型分组为单一表型组相比,活性评分系统可以更准确地预测酶活性。单点血浆样本和唾液样本可作为替代表型分析方法,以方便临床使用。